<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        62-171-08
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2008
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ROMAC 300MG F.C. TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ROXITHROMYCIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        300
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        29.9
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1055]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Dallah Health Care Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01FA06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>ROMAC is the trade name of Roxithromycin, a macrolide antibiotic.</p><p><strong>INDICATIONS</strong><br />ROMAC is indicated in infections due to organisms sensitive to Roxithromycin, particularly the following:<br />-ENT infections: Tonsillitis, pharyngitis, sinusitis, and otitis media.<br />-Respiratory tract infections: Bronchitis, whooping cough and pneumonia, particularly pneumonia due to Chlamydia, Mycoplasma or Legionella.<br />-Uro-genital system infections: Urethritis, cervicitis, and Chlamydia or Mycoplasma cervico-vaginitis (except for gonococcal infections).<br />-Skin infections: Acne, impetigo, impetigo changes in skin disorders, ecthyma, infectious dermohypodermitis (particularly erysipelas), erythrasma, furunculosis, and pyodermitis.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>CONTRAINDICATIONS</strong><br />-Hypersensitivity to Roxithromycin.<br />-Simultaneous intake of cisapride or ergot alkaloids .</p><p><br /><strong>WARNINGS</strong><br />Administration of Roxithromycin is not recommended in patients with impaired liver function. If its use is necessary, liver parameters should be monitored regularly and the dosage reduced if required&nbsp;<br /><br /><strong>PRECAUTIONS</strong><br />-The renal excretion of Roxithromycin is low; dosage need not be modified in patients with renal impairment.<br />-Due to risk of dizziness, caution should be exercised while driving or operating machines.<br />-Eventhough the half life is prolonged in elderly patients, plasma levels achieved at steady state do not differ than those in young subjects; dosage adjustments are not necessary.<br />-At doses of least 10 times higher than the therapeutic dose, abnormalities of the connecting cartilage have been observed in young animals, and it is therefore recommended that the pediatric dosage and duration be not exceeded .<br />-Although no clinically significant changes in biochemical indices have been observed with Roxithromycin treatment, prescribers should be aware of the development of liver intolerance, possibly in the form of hepatic and cholestatic reactions after long periods of treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>DOSAGE</strong><br /><u>Usual adult dose</u><br />ROMAC 300 mg every 24 hours; or ROMAC 150 mg twice daily, morning and evening.<br />Usual pediatric dose<br />The usual pediatric dose of Roxithromycin is 5-8 mg/kg/day in two divided doses, or as follows:<br />-Children 24-40 kg: ROMAC 100 mg twice daily, morning and evening.<br />-Children over 40 kg: ROMAC 150 mg twice daily, morning and evening.<br /><strong>Notes</strong><br />-ROMAC tablets are taken whole, with a large quantity of fluid, preferably before meals.<br />-In adults with severe hepatic dysfunction, ROMAC dose is 150 mg per day.<br />-Treatment is continued for at least 2 days after symptoms have reduced.<br />-In the case of streptococcal infections, treatment must continue for not less than 10 days in order to avoid resultant relapses and complications.&nbsp;<br />-ROMAC 100 Tablet dosage form is not suitable for children below the age of 4 years.<br />-Treatment should not be prolonged beyond 10 days in children.&nbsp;</p><p><strong>OVERDOSE</strong><br />Information on the acute toxicity of Roxithromycin in humans is lacking.<br />In case of overdose, the stomach should be emptied by gastric lavage. Supportive and symptomatic treatment should be initiated. There is no specific antidote for Roxithromycin.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>ADVERSE EFFECTS</strong><br />-Gastrointestinal problems occur occasionally (e.g., nausea, desire to vomit and/or vomiting, gastric pain or diarrhea).<br />-Hypersensitivity mucosal and skin reactions are rarely seen.</p><p>-Very rarely , headaches,dizziness and parestgesia develop.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store according to conditions specified on the package.</p><p>Do not use after the expiry date shown on the package.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>ROMAC is the trade name of Roxithromycin, a macrolide antibiotic.<br />Each ROMAC 100, 150 and 300 Film-Coated Tablet contains Roxithromycin 100, 150 and 300 mg, respectively.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Boxes of 10 ROMAC 100 blistered tablets.
Boxes of 10 ROMAC 150 blistered tablets.
Boxes of 10 ROMAC 300 blistered tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Jordanian Pharmaceutical Manufacturing company LTD</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                June 2001
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>روماك هو الاسم التجاري لروكسيثرومايسين، وهو مضاد حيوي ماكروليدي</p><p><strong>الاستطبابات</strong><br />يستطب روماك في الأخماج التي تسببها كائنات حية حساسة لروكسيثرومايسين، خاصة ما يلي<br />أخماج الأذن والأنف والحلق: التهابات اللوزتين والبلعوم والجيب والأذن الوسطى<br />أخماج السبيل التنفسي: التهاب القصبات والشاهوق (السعال الديكي)، وذات الرئة التي تسببها المتدثرة أو المفطورة أو الفيلقية بشكل خاص<br />أخماج الجهاز البولي التناسلي: التهاب الإحليل والتهاب العنق، والتهاب العنق المهبلي بالمتدثرة أو المفطورة ما عدا أخماج المكورات البنية<br />أخماج الجلد: العُد (حَب الشباب) والبهاق والتغيرات البهاقية في الاعتلالات الجلدية والإكتيمة والتهاب النسيجة تحت الجلد الجلدي (خاصة الحمرة)، والوذح والدمال وتقيّح الجلد</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>مضادات الاستطباب</strong><br />فرط الحساسية لروكسيثرومايسين<br />التناول المتزامن مع سيسابرايد أو قلوانيات الأرغوت<br /><strong>التحذيرات</strong><br />لا يوصى بإعطاء روكسيثرومايسين للمرضى المصابين بضعف في وظيفة الكبد. وإذا كان لا بد من استعماله، يجب مناطرة معالم الكبد بانتظام وخفض الجرعة إذا لزم الأمر&nbsp;&nbsp;<br /><strong>الاحتياطات</strong><br />نظراً لقلة إطراح روكسيثرومايسين بالبول، لا يتوجب تعديل الجرعة في مرضى الضعف الكلوي<br />نظراً لاحتمالية الإصابة بدوام، يجب أخذ الحيطة عند القيادة أو تشغيل الآلات<br />بالرغم من إطالة العمر النصفي في المرضى الكهول فإن تراكيز المصورة المحرزة في الحالة المستتبة لا تختلف عن تلك المحرزة لدى الشباب. لذلك لا يلزم تعديل الجرعات<br />لوحظ في صغار الحيوان المعطاة جرعات أعلى من الجرعات العلاجية بعشرة أضعاف على الأقل شذوذات في غضروف الاتصال. لذلك لا يوصى بتجاوز الجرعة وفترة العلاج الموصى بها في الأطفال<br />على الرغم من أنه لم تلاحظ تغيرات سريرية معتدة في مناسب الكيمياء الحيويـة عند العلاج بروكسيثرومايسين، يجـب على الواصفين الإحاطة بتطور لااحتمال كبدي، قد يكون على شكل تفاعلات كبدية أو ركود صفراوية بعيد فترات العلاج الطويلة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>الجرعة</strong><br /><u>الجرعة الاعتيادية للبالغين</u><br />روماك 300 ملغم كل 24 ساعة، أو روماك 150 ملغم مرتان يومياً صباحاً ومساءً<br /><u>الجرعة الاعتيادية للأطفال</u><br />الجرعة الاعتيادية للأطفال من روكسيثرومايسين هي 5-8 ملغم/كغم/يوم مقسمة على جرعتين أو كما يلي<br />الأطفال من 24-40 كغم: روماك 100 ملغم مرتان يومياً، صباحاً ومساءً<br />الأطفال فوق40 كغم: روماك 150 ملغم مرتان يومياً، صباحاً ومساءً<br /><strong>ملاحظات</strong><br />تؤخذ أقراص روماك صحيحة (دون كسر)، مع كمية كبيرة من السائل، ويفضل تناولها قبل الوجبات<br />جرعة البالغين المصابين باعتلال وخيم في وظيفة الكبد هي روماك 150 ملغم باليوم<br />تستمر المعالجة لمدة يومين على الأقل من بعد تخفيف الأعراض<br />في حالة أخماج العنقودية يجب متابعة العلاج لمدة لا تقل عن 10 أيام لتفادي النكس والمضاعفات الناتجة<br />لا تناسب أقراص روماك 100 كشكل صيدلاني الأطفال دون الرابعة<br />يجب أن لا تتجاوز فترة العلاج في الأطفال عشرة أيام&nbsp;<br /><strong>فرط الجرعة</strong><br />لا تتوفر معلومات عن السمية الحادة لروكسيثرومايسين لدى البشر<br />في حالة فرط الجرعة، يجب إفراغ المعدة بالغسيل المعدي، وتستهل المعالجة الداعمة والعرضية. ليس هناك درياق خاص لروكسيثرومايسين</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p><strong>الآثار الجانبية</strong><br />تظهر أحيانا مشاكل معدية معوية مثلا: غثيان، رغبة في القيء و/أو قياء، ألم معدي أو إسهال<br />نادراً ما تظهر تفاعلات مخاطية أو جلدية فرط تحسسية<br />يظهر في حالات نادرة جداً صداع ودوام ومذل</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ حسب ظروف الحفظ المبينة على الغلاف</p><p>لا ينبغي استعمال الدواء بعد تاريخ انتهاء الصلاحية المبين على الغلاف</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>روماك هو الاسم التجاري لروكسيثرومايسين، وهو مضاد حيوي ماكروليدي<br />كل قرص ملبس من روماك 100 و 150 و 300 يحتوي على روكسيثرومايسين 100 و 150 و 300 ملغم على التوالي</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            علب تحتوي على 10 أقراص روماك 100 محفوظة في أشرطة.
علب تحتوي على 10 أقراص روماك 150 محفوظة في أشرطة.
علب تحتوي على 10 أقراص روماك 300 محفوظة في أشرطة.
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة الأردنية لإنتاج الأدوية المساهمة العامة&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            حزيران 2001
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ROMAC 300 film- coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active ingredient:

           Roxithromycin 300 mg

Inactive ingredients:


Ingredient	Quantity
mg/tab.
Microcrystalline Cellulose 50 micrometer  	102.22
Colloidal anhydrous silica 	13.46
Croscarmellose sodium	32.61
Magnesium Stearate	5.74
Hydroxypropyl cellulose 	13.89
Polyethylene glycol 4000	4.80
Titanium dioxide 	3.96
Hydroxyl propyl methyl cellulose Type 2910 	9.90
Polyethylene glycol 400	1.19


      *For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                White to off white shallow biconvex oval embossed with “RC300” on one side and plain on the other side film coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Adults</u></strong></p><p><strong><u>&nbsp;</u></strong></p><p>ROMAC is indicated for the treatment of the following types of mild to &nbsp;&nbsp;moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms:</p><p>&nbsp;</p><p>q&nbsp; URTI: acute pharyngitis, tonsillitis, sinusitis</p><p>q&nbsp; LRTI: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia</p><p>q&nbsp; Skin and skin structure infections</p><p>q&nbsp; Non gonococcal urethritis.</p><p>&nbsp;</p><p><strong><u>&nbsp;Children</u></strong></p><p><strong><u>&nbsp;</u></strong></p><p>&nbsp;ROMAC tablets are indicated for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible micro-organisms:</p><p>q&nbsp; Acute pharyngitis</p><p>q&nbsp; Acute tonsillitis</p><p>q&nbsp; Impetigo</p><p>Appropriate culture and sensitivity tests should be performed when necessary to determine an organism&rsquo;s susceptibility and thus treatment suitability. Therapy with Roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Route of administration: Oral</p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;<u>Adults </u></strong></p><p>ROMAC should be taken at least 15 minutes before food or on an empty stomach (i.e. more than 3 hours after a meal).</p><p>The recommended dosage is 300mg per day which may be taken according to one of the following alternative dosage regimens:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:551px"><tbody><tr><td rowspan="2" style="vertical-align:top"><p><strong>&nbsp;</strong></p><p><strong>Usual dosage</strong></p></td><td style="vertical-align:top"><p><strong>ROMAC 300 mg Tablets</strong></p></td><td style="vertical-align:top"><p><strong>ROMAC 150 mg Tablets</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>One tablet daily</p></td><td style="vertical-align:top"><p>One tablet twice daily or Two tablets once daily</p></td></tr><tr><td style="vertical-align:top"><p><strong>Elderly</strong></p></td><td style="vertical-align:top"><p>One tablet daily</p></td><td style="vertical-align:top"><p>One tablet twice daily or Two tablets once daily</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Impaired renal function</strong></p></td><td style="vertical-align:top"><p>One tablet daily</p></td><td style="vertical-align:top"><p>One tablet twice daily or Two tablets once daily</p></td></tr></tbody></table><p>&nbsp;</p><p>For atypical pneumonia, the recommended dosage is one 150 mg tablet twice daily.</p><p>ROMAC 150mg and 300mg film-coated tablets must be swallowed whole with a drink.</p><p>The usual duration of treatment is 5 to 10 days depending on the indication and clinical response.</p><p>Streptococcal throat infections require at least 10 days of therapy. A small proportion of patients with non-gonococcal genital infections may require 20 days for complete cure.</p><p>&nbsp;</p><p><strong><u>Children</u></strong></p><p>&nbsp;</p><p>The recommended dose and duration of treatment should NOT be exceeded in children (see Precautions).</p><p>ROMAC should be taken at least 15 minutes before food or on an empty stomach (i.e. more than 3 hours after a meal).</p><p>ROMAC is administered twice daily at a dose of 5 to 8 mg/kg per day.</p><p>For children 40 kg and over: One ROMAC 150 mg tablet morning and evening.</p><p>The usual duration of treatment is five to ten days depending on the indication and clinical response. Streptococcal throat infections require ten days of therapy. The duration of treatment should not exceed ten days.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	Known hypersensitivity to macrolides, including erythromycin.
	Severely impaired hepatic function (see ‘PRECAUTIONS’).
	Concomitant therapy with vasoconstrictive ergot alkaloids (see‘INTERACTIONS WITH OTHER MEDICINES’).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety of Roxithromycin has not been demonstrated in patients with impaired hepatic or renal function. Caution should be exercised if Roxithromycin is administered to patients with impaired hepatic or renal function. If administered to patients with severe impaired hepatic function (eg. hepatic cirrhosis with jaundice and/or ascites), consideration should be given to reducing the daily dosage to half the usual dosage.</p><p>Prolonged or repeated use of antibiotics including Roxithromycin may result in superinfection by resistant organisms. In the event of superinfection, Roxithromycin should be discontinued and appropriate therapy instituted.</p><p>When indicated, incision, drainage or other appropriate surgical procedures should be performed in conjunction with antibiotic therapy.</p><p>Antibiotic associated pseudomembranous colitis has been reported with many antibiotics.&nbsp; A toxin produced by <em>Clostridium difficile</em> appears to be the primary cause. The severity of the colitis may range from mild to life threatening. It is important to consider this diagnosis in patients who develop diarrhoea or colitis in association with antibiotic use (this may occur up to several weeks after cessation of antibiotic therapy). Mild cases usually respond to drug discontinuation alone.</p><p>However, in moderate to severe cases, appropriate therapy with a suitable oral antibacterial agent effective against <em>Clostridium difficile</em> should be considered. Fluids, electrolytes and protein replacement therapy should be provided when indicated.</p><p>Drugs which delay peristalsis, eg. opiates and diphenoxylate with atropine may prolong and/or worsen the condition and should not be used.</p><p>&nbsp;</p><p>Roxithromycin, like erythromycin, has been shown in vitro to elicit a concentration &ndash; dependent lengthening in cardiac action potential duration. Such an effect is manifested only at supra &ndash; therapeutic concentrations. Accordingly, the recommended doses should not be exceeded.</p><p>In certain conditions macrolides, including roxithromycin, have the potential to prolong the QT interval. Therefore Roxithromycin should be used with caution in patients with congenital prolongation of the QT interval, with ongoing proarrhythmic conditions (ie uncorrected hypokalemia or hypomagnesaemia, clinically significant bradycardia), and in patients receiving Class IA and III antiarrhythmic agents (see INTERACTIONS WITH OTHER MEDICINES).</p><p>As with other macrolides, Roxithromycin may have the potential to aggravate myasthenia gravis.</p><p>&nbsp;</p><p>Severe bullous reactions: &nbsp;Cases of severe bullous skin reactions such as Stevens Johnson syndrome (SJS) or toxic epidermal necrosis (TEN) have been reported with Roxithromycin.&nbsp; &nbsp;If symptoms or signs of SJS<em>&nbsp; &nbsp;</em>or TEN (e.g. progressive &nbsp;skin rash often with blisters &nbsp;or mucosal &nbsp;lesions) are present, &nbsp;the treatment &nbsp;should be discontinued.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Roxithromycin has a much lower affinity for cytochrome P450 than erythromycin and consequently has fewer interactions. Interactions may be observed, however, with drugs that bind to alpha-1acid glycoprotein, such as disopyramide.</p><p>&nbsp;</p><p>Roxithromycin does not appear to interact with oral contraceptives containing oestrogens and progestogens, prednisolone, carbamazepine, ranitidine or antacids.</p><p>&nbsp;</p><p><u>Theophylline </u></p><p>A study in normal subjects concurrently administered Roxithromycin and theophylline has shown some increase in plasma concentration of the latter. While a change in dosage is usually not required, patients with high levels of theophylline at commencement of treatment should have levels monitored.</p><p><u>Ergot alkaloids</u></p><p>Reactions of ergotism with possible peripheral necrosis have been reported after concomitant therapy of macrolides with vasoconstrictive ergot alkaloids, particularly ergotamine and dihydroergotamine. Because a clinical interaction with Roxithromycin cannot be excluded, administration of Roxithromycin to patients taking ergot alkaloids is contraindicated.</p><p><u>Disopyramide</u></p><p>An in-vitro study has shown that Roxithromycin can displace protein bound disopyramide; such an effect in vivo could result in increased serum levels of disopyramide. Consequently ECG and, if possible, disopyramide serum levels should be monitored.</p><p><u>Terfenadine</u></p><p>Certain&nbsp; macrolides&nbsp; are capable of a pharmacokinetic&nbsp;&nbsp; interaction&nbsp; with terfenadine leading to increased&nbsp; serum concentrations&nbsp; of the latter. This may result&nbsp; in severe ventricular&nbsp; arrhythmia,&nbsp; typically&nbsp; torsades&nbsp; de pointe. Although&nbsp; such a reaction&nbsp; has not been demonstrated&nbsp; with Roxithromycin&nbsp; and studies&nbsp; in a limited&nbsp; number&nbsp; of healthy volunteers&nbsp; have not shown any pharmacokinetic&nbsp;&nbsp; interaction&nbsp; or relevant ECG changes,&nbsp; the association&nbsp; of Roxithromycin&nbsp; and terfenadine&nbsp; is not recommended.</p><p><u>Astemizole, Cisapride, Pimozide</u></p><p>Other drugs, such as astemizole, cisapride or pimozide, which are metabolized by the hepatic isozyme CYP3A4, have been associated with QT interval prolongation and/or cardiac arrhythmias (typically Torsades de Pointes) as a result of an increase in their serum level subsequent to interaction with significant inhibitors of this isozyme, including some macrolide antibacterials.</p><p>Although Roxithromycin has no or limited ability to complex CYP3A4 and therefore to inhibit the metabolism of other drugs processed by this isozyme, a potential for clinical interaction of Roxithromycin with the above mentioned drugs cannot be either ascertained or ruled out in confidence; therefore, concomitant administration of Roxithromycin and such drugs is not recommended.</p><p><u>Warfarin</u></p><p>While no interaction was observed in volunteer studies, Roxithromycin appears to interact with warfarin. Increases in prothrombin time (international normalized ratio; INR) have been reported in patients treated concomitantly with Roxithromycin and warfarin or the related Vitamin K antagonist &nbsp;phenprocoumon, and severe bleeding episodes have occurred as a consequence. INR should be monitored during combined treatment with Roxithromycin and Vitamin K antagonists.</p><p><u>Digoxin and Other Cardiac Glycosides</u></p><p>A study in healthy volunteers has shown that Roxithromycin may increase the absorption of digoxin.</p><p>This effect, common to other macrolides, may very rarely result in cardiac glycoside toxicity. This may be manifested by symptoms such as nausea, vomiting, diarrhoea, headache or dizziness; cardiac glycoside toxicity may also elicit heart conduction and/or rhythm disorders. Consequently, in patients treated with Roxithromycin and digoxin or another cardiac glycoside, ECG and, if possible, the serum level of the cardiac glycoside should be monitored; this is mandatory if symptoms which may suggest cardiac glycoside overdosage occur.</p><p><u>Midazolam</u></p><p>Roxithromycin, like other macrolides, may increase the area under the midazolam concentration- time curve and the midazolam half-life; therefore the effects of midazolam may be enhanced and prolonged in patients treated with roxithromycin. There is no conclusive evidence for an interaction between roxithromycin and triazolam.</p><p><u>Theophylline and Cyclosporin</u></p><p>A slight increase in plasma concentrations of theophylline or cyclosporin A has been observed.</p><p>This does not generally necessitate altering the usual dosage.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1-1-1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use during pregnancy</p><p>Reproductive studies in rats, mice and rabbits at doses of 100, 400 and 135mg/kg/day, respectively, did not demonstrate evidence of developmental abnormalities. In rats, at doses above 180 mg/kg/day, there was evidence of embryotoxicity and maternotoxicity. The safety of Roxithromycin for the human foetus has not been established.</p><p>1-1-2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use during lactation</p><p>Small amounts of Roxithromycin are excreted in the breast milk. Breast feeding or treatment of the mother should be discontinued as necessary</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Attention should be drawn to the possibility of dizzy sensations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Roxithromycin is generally well tolerated. In clinical trials, treatment discontinuation due to adverse reactions occurred in only 1.2% of adult patients and 1.0% of children. The following side-effects or serious adverse events possibly associated with roxithromycin have been reported:</p><p><u>Gastrointestinal</u></p><p>Nausea, vomiting, epigastric pain (dyspepsia), diarrhoea (sometimes containing blood), anorexia, flatulence. In clinical studies, the incidence of gastrointestinal events was higher with the 300 mg once daily dosage regimen than with 150 mg twice daily.</p><p>Symptoms&nbsp; of pancreatitis&nbsp; have been observed;&nbsp; most patients&nbsp; had received&nbsp; other drugs for which pancreatitis&nbsp; is a known&nbsp; adverse reaction,&nbsp; pseudomembranous&nbsp;&nbsp; colitis</p><p>&nbsp;</p><p><u>&nbsp;Infections &nbsp;and infestations: </u></p><p><u>&nbsp;</u></p><p>Superinfection:&nbsp; As with other antibiotics, the use of Roxithromycin,&nbsp; especially&nbsp; if prolonged,&nbsp; may result in overgrowth&nbsp; of non- susceptible&nbsp; organisms.&nbsp; Repeated evaluation of the patient&#39;s&nbsp; condition&nbsp; is essential. If superinfection&nbsp; occurs&nbsp; during therapy,&nbsp; appropriate&nbsp; measures&nbsp; should be taken.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Ear and labyrinth &nbsp;disorders: &nbsp;</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Temporary deafness, &nbsp;hypoacusis, vertigo</p><p><u>Blood and lymphatic&nbsp; system&nbsp; disorders: </u></p><p>Eosinophilia, agranulocytosis, neutropenia,&nbsp; thrombocytopenia</p><p><u>Respiratory,&nbsp; thoracic&nbsp; and mediastinal&nbsp; disorders: </u></p><p>Bronchospasm.</p><p><u>Hypersensitivity&nbsp; </u></p><p>Urticaria, rash, pruritus, angioedema. Rarely, serious allergic reactions may occur such as asthma, bronchospasm, anaphylactic-like reactions, anaphylactic shock, purpura, glottic oedema, generalised oedema, erythema multiforme, exfoliative dermatitis, Stevens-Johnson Syndrome.</p><p><u>Liver</u></p><p>Moderate increase in serum transaminases, AST-ALT and/or alkaline phosphatase levels have been observed and are somewhat more likely to occur in the elderly (&gt; 65 years of age). Acute cholestatic hepatitis and acute hepatocellular injury (sometimes with jaundice), are rarely reported.</p><p><u>Others</u></p><p>Hallucination, headache, dizziness, paraesthesia, tinnitus, malaise, moniliasis, disorders of taste and/or smell.</p><p>&nbsp;</p><p>To report any side effect (s):</p><p>Saudi Arabia: National Pharmacovigilance &amp; Drug Safety Centre (NPC)</p><p>q&nbsp; Fax: +966-11-205-7662</p><p>q&nbsp; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>q&nbsp; Toll free phone: 8002490000</p><p>q&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>q&nbsp; Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptomatic treatment should be provided as required. There is no specific antidote.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group:<strong> </strong>Antibacterial, Macrolids</p><p><strong>&nbsp;</strong>ATC Code: J01FA06</p><p>Roxithromycin is a semi-synthetic macrolide antibiotic. It is very similar in composition, chemical structure and mechanism of action to erythromycin, azithromycin, or clarithromycin. Roxithromycin has the following antibacterial spectrum in vitro: <em>Streptococcus agalactiae</em>, <em>Streptococcus pneumoniae</em> (Pneumococcus), <em>Neisseria meningitides</em> (Meningococcus), <em>Listeria monocytogenes</em>, <em>Mycoplasma pneumoniae</em>, <em>Chlamydia trac</em>homatis, <em>Ureaplasma urealyticum</em>, <em>Legionella pneumophila</em>, <em>Helicobacter </em>(Campylobacter), <em>Gardnerella vaginalis</em>, <em>Bordetella pertussis</em>, <em>Moraxella catarrhalis</em> (Branhamella Catarrhalis), and <em>Haemophilus du</em>creyi. Roxithromycin is highly concentrated in polymorphonuclear leukocytes and macrophages, achieving intracellular concentrations greater than those outside the cell. Roxithromycin enhances the adhesive and chemotactic functions of these cells which in the presence of infection produce phagocytosis and bacterial lysis. Roxithromycin also possesses intracellular bactericidal activity.</p><p><u>Mechanism of action</u></p><p>Roxithromycin prevents bacteria from growing, by interfering with their protein synthesis. Roxithromycin binds to the subunit 50S of the bacterial ribosome, and thus inhibits the translocation of peptides. Roxithromycin has similar antimicrobial spectrum as erythromycin, but is more effective against certain gram-negative bacteria, particularly <em>Legionella pneumophila.</em></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Roxithromycin is absorbed after oral administration with an absolute bioavailability approximately 50%. Peak plasma concentrations following administration of 150mg and 300mfilm-coated tablets are achieved in young and elderly adult patients approximately 1 to 2 hourpost-dose.&nbsp; However, Rulide D 50 mg tablets for suspension appear to be absorbed more slowthan the Rulide film-coated tablets, with peak plasma concentrations achieved approximatelhours post dose.</p><p>As food intake decreases absorption, Rulide should be administered at least 15 minutes beforfood or, alternatively, on an empty stomach (i.e. more than 3 hours after a meal).</p><p>Absorption is not linear; with increasing doses in the range 150mg to 300mg, peak plasma levand AUC do not increase in proportion to the dose.</p><p>After repeated administration of 2.5mg/kg every 12 hours to children, the average peak plasconcentration at steady state was 9mg/L and the AUC was 61mg.h/L.</p><p>Following administration of a single oral dose of Rulide 150 mg to healthy young adults, the mpeak plasma concentration was 6.6 mg/L and the AUC was 69mg.h/L. At steady state followdoses of 150 mg twice daily, the mean peak plasma concentration was 9.3 mg/L and the AUC w 71mg.h/L.</p><p>In elderly patients, the mean peak plasma concentration following a single 150 mg dose wasmg/L and the AUC was 148mg.h/L. At steady state, a dosage regimen of 150 mg twice daiproduced a mean peak plasma concentration of 11.3mg/L and an AUC of 83mg.h/L.</p><p>Following administration of a single oral dose of Rulide 300 mg to healthy young adults, the mpeak plasma concentration was 9.7 mg/L and the AUC was 98mg.h/L. At steady state followdoses of 300 mg once daily, the mean peak plasma concentration was 10.9mg/L and the AUC w77mg.h/L.</p><p>In elderly patients, the mean peak plasma concentration following a single 300 mg dose was 10.8 mg/L and the AUC was 197mg.h/L.</p><p><u>Distribution</u></p><p>Roxithromycin is 92-96% bound to plasma proteins (principally alpha-1-acid glycoprotein, but also albumin) at concentrations less than 4.2mg/L. The binding is saturable: in subjects with normal plasma levels of alpha-1-acid glycoprotein, the extent of binding decreases when plasma concentrations of roxithromycin exceed 4.2mg/L. At a plasma concentration of 8.4mg/L, approximately 87% of the drug is protein bound.</p><p>Roxithromycin is highly concentrated in polymorphonuclear leucocytes and macrophages, where levels 30 times those in serum have been reported.</p><p><u>Elimination </u></p><p>The mean half-life of Roxithromycin is approximately 12 hours in young adults and 20 hours in children. The apparently longer half life in children does not cause excessive accumulation: Cmin and AUC values are comparable for adults and children.</p><p>The half-life is prolonged to 25 hours in adults with impaired hepatic function and 18 hours in adults with renal insufficiency.</p><p>The mean half-life in elderly patients is approximately 27 hours.</p><p><u>Metabolism </u></p><p>Roxithromycin undergoes limited metabolism in the body, presumably in the liver. The major metabolite is descladinose roxithromycin. Two minor metabolites have also been identified. Plasma levels of roxithromycin are approximately twice those of all metabolites; a similar ratio is seen in the urine and faeces.</p><p>Approximately 7% of a dose is excreted in the urine and 13% is eliminated via the lungs. Faecal excretion, which represents the unabsorbed fraction and the small proportion excreted by the liver, accounts for approximately 53% of the dose. The fate of the remainder is unknown.</p><p>When roxithromycin plasma levels are above 4.2mg/L, renal clearance increases because reduced plasma protein binding (see &lsquo;Distribution&rsquo;) causes increased levels of unbound roxithromycin, which may be excreted by the kidneys.&nbsp;&nbsp;&nbsp;</p><p><u>Microbiology</u></p><p>Roxithromycin is bacteriostatic at low concentrations and bactericidal at high concentrations. It binds to the 50S subunit of the 70S ribosome thereby disrupting bacterial protein synthesis.</p><p>A prolonged post antibiotic effect has been observed with roxithromycin. Whilst the clinical significance of this remains uncertain, it supports the rationale for once daily dosing. Although clinical data has demonstrated the efficacy and safety of once daily dosing in adults, this has not been demonstrated in children.</p><p>At plasma concentrations achieved with the recommended therapeutic doses, roxithromycin has been demonstrated to have in vitro and clinical activity against the following microorganisms:</p><p><em>Streptococcus pneumoniae</em>, <em>Streptococcus pyogenes</em>, <em>Mycoplasma pneumoniae</em>, <em>Moraxella catarrhalis</em>, <em>Ureaplasma urealyticum</em>, Chlamydia spp.</p><p>Roxithromycin has been demonstrated to have clinical activity against the following microorganisms which are partially sensitive in vitro to roxithromycin:</p><p><em>Haemophilus influenzae</em>, <em>Staphylococcus aureus</em> (except MRSA).</p><p>The following strains of microorganisms are resistant:</p><p>Multiresistant <em>Staphylococcus aureus</em>, Enterobacteriaceae, Pseudomonas spp., Acinetobacter spp.</p><p><u>Susceptibility Tests</u></p><p>Dilution or diffusion techniques &ndash; either quantitative (MIC) or breakpoint, should be used following a regularly updated, recognised and standardised method (eg NCCLS). Standardised susceptibility test procedures require the use of laboratory control microorganisms to control the technical aspects of the laboratory procedures.</p><p>A report of &quot;Susceptible&quot; indicates that the pathogen is likely to be inhibited if the antimicrobial compound in the blood reaches the concentrations usually achievable. A report of &quot;Intermediate&quot; indicates that the result should be considered equivocal, and if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. This category implies possible clinical applicability in body sites where the drug is physiologically concentrated or in situations where high dosage of drug can be used. This category also provides a buffer zone, which prevents small-uncontrolled technical factors from causing major discrepancies in interpretation. A report of &quot;Resistant&quot; indicates that the pathogen is not likely to be inhibited if the antimicrobial compound in the blood reaches the concentrations usually achievable; other therapy should be selected.</p><p>Note: The prevalence of resistance may vary geographically for selected species and local information on resistance is desirable, particularly when treating severe infections.</p><p>Using the NCCLS method of susceptibility testing with a 15mcg roxithromycin disc, susceptible &nbsp;organisms other than <em>Haemophilus influenzae</em> produce zones of inhibition 21mm or greater.&nbsp; A zone size of 10 to 20mm should be considered intermediate and a zone size of 9mm or less indicates resistance. A bacterial isolate may be considered susceptible if the MIC value for roxithromycin is less than or equal to 1 mg/L. Organisms are considered resistant if the MIC value is greater than 8 mg/L.</p><p>For <em>Haemophilus influenzae</em>, zones of inhibition 10 mm or greater indicate susceptibility when CO<sub>2 </sub>considered susceptible if the MIC value for roxithromycin is less than or equal to 8mg/L.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>v</p><p>Long term studies in animals have not been performed to evaluate the carcinogenic potential of roxithromycin. Roxithromycin has shown no mutagenic potential in standard laboratory tests for gene mutation and chromosomal damage.</p><p>There was no effect on the fertility of rats treated with roxithromycin at oral doses up to180mg/kg/day. &nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>q&nbsp; Microcrystalline Cellulose 50 micrometer&nbsp;</p><p>q&nbsp; Colloidal anhydrous silica</p><p>q&nbsp; Croscarmellose sodium</p><p>q&nbsp; Magnesium Stearate</p><p>q&nbsp; Hydroxypropyl cellulose</p><p>q&nbsp; Polyethylene glycol 4000</p><p>q&nbsp; Titanium dioxide</p><p>q&nbsp; Hydroxyl propyl methyl cellulose Type 2910</p><p>q&nbsp; Polyethylene glycol 400</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ROMAC 300 Tablets should not be stored at a temperature above 30&ordm;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ROMAC 300 Tablets are packed in boxes of 10 Tablets blistered in aluminium foil.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p><p>&nbsp;Any unused product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Jordanian Pharmaceutical Manufacturing Co. Ltd.
PO Box 151
Um Al-Amad 16197
Jordan

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                September 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>